antibiotic resistance News
-
HORIBA Medical participated to the 2015 West Medica Africa exhibition
Our CRP specialists presented the new HORIBA Medical CRP range at the West Medica Africa exhibition, which was held at the Eko Convention Centre in Lagos (Nigeria), from October 12th to 14th, 2015. Our workshop on antibiotic resistance was a great success! For more information on this event, please click ...
-
Multidrug-resistant bacteria remain a public health issue in Europe
On the occasion of the European Antibiotic Awareness Day, ECDC is releasing new European-wide surveillance data on antibiotic resistance from the European Antimicrobial Resistance Surveillance Network (EARS-Net). With annually up to 400,000 patients reported to suffer from infections resistant to multiple antibiotics, the data show that antibiotic resistance remains a public health problem across ...
-
EFSA adopts opinion on antibiotic resistant bacteria
EFSA’s Panel on Biological Hazards (BIOHAZ) has adopted an opinion on the role of food consumption and processing in human exposure to antimicrobial resistant (AMR) bacteria, an emerging biological hazard caused in part by the use of antimicrobial agents throughout the food chain, from the farm to the fork. The opinion, “Foodborne antimicrobial resistance as a biological hazard”, says that the ...
-
Selux Diagnostics Receives $9.6 Million in Additional Funding, Speeding Development of Breakthrough Rapid AST Platform
Selux Diagnostics, Inc., which is leading a new era in personalized medicine to treat superbug infections and combat antibiotic resistance, today announced that it has been awarded an additional $9.6 million from the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and ...
-
ID Genomics’ CLoNeT E. coli Assay in Development to Combat Antibiotic Resistant Urinary Tract Infections
ID Genomics, SPC today announced the completion of its first Pre-Submission meeting with the Food and Drug Administration for the CLoNeT E. coli Assay for Urinary Tract Infections (UTIs). “We continue to make great strides in our development plans for the CLoNeT E. coli Assay,” said Linda Zuckerman, Ph.D., President and CEO. “This unique product will be able to detect the ...
-
NRDC: President’s Executive Order, Science Advisors’ Report Sound Alarm on Antibiotic Resistance but Lack Needed Reforms for Curbing Livestock Drug Use
In response to a long awaited report and new executive actions to combat antibiotic resistance announced today by the President’s Council of Advisors on Science and Technology (PCAST), Mae Wu, health attorney at the Natural Resources Defense Council (NRDC), issued the following statement: “Today’s report from the President’s science advisors underscores the crisis ...
-
Senator Brian Kavanagh, Assemblywoman Linda Rosenthal, and Over 70 Groups Advocate for Passage of bill that will reduce threat of antibiotic-resistant superbugs
Senator Brian Kavanagh and Assemblywoman Linda Rosenthal joined NYPIRG, Consumer Reports, Center for Food Safety, and over 70 national and state environmental, health, and consumer organizations today to call on the State Legislature and the Governor to take action in the state budget against the immediate and growing threat to the public's health posed by antibiotic-resistant "superbugs." ...
-
Vaxdyn introduces its multi-pathogen vaccine candidate KapaVax at the World Vaccine Congress Europe
In an oral presentation within the track “AMR & Bacterial Vaccines”, chaired by Dr Jan Poolman (Bacterial Vaccine Discovery and Early Development, Janssen), Dr. Infante showed how Vaxdyn’s technology can deliver endotoxin-free inactivated whole cell vaccines presenting outer-membrane proteins of different bacteria in the surface, therefore raising immunity against ...
-
FDA’s New Antibiotics Policy Fails to Protect Health
The U.S. Food & Drug Administration today released a long pending policy that lays out a voluntary approach to reducing the use of antibiotics in animals that are not sick. The policy, known as Guidance 213, was widely criticized by NRDC and other public interest organizations when it was released in draft form in April 2012, because it fails to require any changes in the use of antibiotics. ...
-
CDC: Foster Farms Salmonella Outbreak Not Over
More than two months after declaring the outbreak appeared to be over, the Centers for Disease Control and Prevention (CDC) has reported an additional 43 people sickened by strains of Salmonella linked to Foster Farms chicken – more than 500 people have reportedly been infected in total. Sixty percent of the tested Salmonella taken from outbreak patients has been resistant to at least one ...
-
Antibiotic Resistance Threats Report Recently Published by the CDC Discussed in New Online Video
Today the IAQ Video Network and Cochrane & Associates announced the release of their latest educational video. Their newest production discusses the Antibiotic Resistance Threats in the United States, 2019 (2019 AR Threats Report) published by the Centers for Disease Control and Prevention (CDC). “This document is an update to the CDC’s first AR Threats Report which was produced ...
-
Burying or burning garbage boosts airborne bacteria, antibiotic resistance genes
Environmental Science & Technology Municipal solid waste is trash — such as plastic, food scraps and lawn clippings — that goes into garbage bins and doesn’t get recycled. Most of this waste is buried in landfills or is incinerated. Now, researchers reporting in ACS’ Environmental Science & Technology have shown that when disposed of in this way, municipal ...
-
A project led by Vaxdyn receives funding from Next Generation EU Funds
The project “AMReady: Development and manufacturing of vaccines for alleviation and preparedness for anti-microbial resistance global health crisis”, to be executed in 2021-2024 with a total budget of 1.4 million euro has been awarded funding by the competitive program Lineas Estratégicas de Colaboración Público-Privada 2021 of the State Research Agency of the ...
-
Antibiotic Resistance Threats Identified by the CDC and the Importance of Infection Control Procedures and Education
While much of the media’s attention has been focused on the novel coronavirus that spread across the globe this year, SARS-CoV-2 is not the only emerging threat. Just before reports of the initial outbreak of COVID-19 last year, the Centers for Disease Control and Prevention (CDC) published an update to the agency’s first Antibiotic Resistance Threats in the United States (AR Threats ...
-
ID Genomics Awarded Prestigious Longitude Prize Discovery Award
Today, Seattle-based ID Genomics, Inc.was awarded a grant from the Longitude Prize Discovery Awards, a seed funding program to help teams competing to win the prestigious Longitude Prize. Run by innovation foundation Nesta and supported by Innovate UK as funding partner, the Longitude Prize is a £10 million prize fund to create a cost-effective, rapid and easy-to-use diagnostic test for ...
-
The GRAM paper gives face to the AMR crisis - Vaxdyn’s comment about the GRAM paper
The experts of the Anti-Microbial Resistance (AMR) world, including Vaxdyn’s researchers, have been warning about the entrance into a post-antibiotic era or the occurrence of a silent pandemic for years. However, the general public, including health practitioners, did not understand the message or underscored the magnitude of the problem. Recently, a vast network of AMR experts around the ...
-
MicrobioSeq’s Plasmid Identification Service Boosts Microbial Characterization Research
MicrobioSeq is the microbial genomics division on behalf of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a renowned reputation for providing reliable sequencing, genotyping, microarray, and bioinformatics services. The product manager is pleased to announce the launch of the Plasmid Identification service, thus helping researchers to efficiently ...
By CD Genomics
-
ID Genomics Social Purpose Corporation Report, 2018
Antimicrobial resistance threatens the very core of human healthcare. ID Genomics’ Social Purpose is simple: to limit bacterial resistance and preserve antibiotics for the good of mankind. We believe that antimicrobial resistance connects every human on the planet and that everyone has a right to be protected from this threat. While our core business focuses on developing diagnostics to ...
-
MicrobioSeq Releases PCR-based Microbial Antibiotic Resistance Gene Analysis Service
MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics MicrobioSeq is committed to delivering comprehensive microbial solutions to human health, agriculture, the environment, and industry by characterizing microbiomes and leveraging microorganisms. The company has recently announced the launch of PCR-based microbial antibiotic resistance ...
By CD Genomics
-
Inflammatix Announces Additional $12.1 Million Funding from BARDA for ViraBac EZ Acute Infection Test
Inflammatix, a pioneering molecular diagnostics company, announced today a contract extension of $12.1 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response. The funding is part of a BARDA contract worth up to $72 million if all options are ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you